LOS ANGELES, CA / ACCESSWIRE / September 29, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Teva Pharmaceutical Industries Limited (“Teva” or the “Company”) (NYSE: TEVA) regarding possible violations of federal securities laws from November 15, 2016 through August 2, 2017, inclusive (the “Class Period”). Investors, who purchased or otherwise acquired Teva shares during the Class Period, should contact the firm prior October 23, 2017, the lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, throughout the Class Period, Teva made false and/or misleading statements and/or failed to disclose that the poor performance of its U.S. generics business resulted in recording a goodwill impairment charge related to the acquisition of Actavis Generics and was a key factor in cutting the Company’s dividend by 75%. Upon this news, shares of Teva dropped in value materially, which caused investors harm according to the Complaint.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 476730

LOS ANGELES, CA / ACCESSWIRE / September 29, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against MAXIMUS, Inc. (“MAXIMUS” or the “Company”) (NYSE: MMS) for possible violations of federal securities laws from October 30, 2014 through February 3, 2016, inclusive (the “Class Period”). Investors, who purchased or otherwise acquired MAXIMUS shares during the Class Period, should contact the firm before the October 6, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet, and until a class is certified, you are not considered to be represented by an attorney. You may also choose to do nothing and be an absent class member.

The Complaint alleges that throughout the Class Period, MAXIMUS made false and/or misleading statements and/or failed to disclose that: in obtaining the Health Assessment Advisory Service (“HAAS”) contract, the Company set an unattainable target number of healthcare professionals to recruit and an unattainable target number of assessments; that throughout the HAAS contract, MAXIMUS was struggling to recruit, train and ramp-up new healthcare staff to perform the assessments; that the inability to meet its target number of healthcare recruits and target number of assessments, meant MAXIMUS would not earn the performance-based incentive fees from the HAAS contract; and that, as a result, the Company’s statements about its financial condition, and the outlook for its business, including statements about the HAAS contract and the amount of revenue MAXIMUS expected the contract to contribute, lacked a reasonable basis when made. Upon this news, MAXIMUS’ stock price fell materially, which harmed investors according to the lawsuit.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may constitute Attorney Advertising in certain jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 476718

LOS ANGELES, CA / ACCESSWIRE / September 29, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Electronics for Imaging, Inc. (“Electronics for Imaging” or the “Company”) (NASDAQ: EFII) for possible violations of federal securities laws from February 22, 2017 through August 3, 2017, inclusive (the “Class Period”). Investors, who purchased or otherwise acquired the Company’s shares during the Class Period, should contact the firm prior to the October 10, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet, and until a class is certified, you are not considered to be represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, throughout the Class Period, Electronics for Imaging made false and/or misleading statements and/or failed to disclose: that the Company improperly recognized revenue; that the Company’s disclosure controls and procedures were not effective; that the Company’s internal control over financial reporting was not effective; and thus, the Company’s public statements were materially false and misleading at all relevant times. Upon release of this news, the share price of Electronics for Imaging dropped materially, which harmed investors according to the lawsuit.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding the rights of shareholders.

This press release may constitute Attorney Advertising in certain jurisdictions under the applicable law and rules of ethics.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 476719

LOS ANGELES, CA / ACCESSWIRE / September 29, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Sequans Communications S.A. (“Sequans” or the “Company”) (NYSE: SQNS) regarding possible violations of federal securities laws from April 29, 2016 through July 31, 2017, inclusive (the “Class Period”). Investors who purchased or otherwise acquired Sequans shares during the Class Period should contact the firm prior to the October 10, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet, and until a class is certified, you are not considered to be represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, during the Class Period, Sequans made false and/or misleading statements, and/or failed to disclose, that the Company was improperly recognizing revenue, and as a result, its public statements were materially false and misleading at all relevant times. On August 1, 2017, Sequans announced that its revenue in the second quarter was negatively affected by a product return from an early 2016 sale related to the tablet business. Upon this news, Sequans’ stock price decreased materially, which caused investors harm.

Lundin Law PC was created by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding the rights of shareholders.

This press release may constitute Attorney Advertising in certain jurisdictions under the applicable law and rules of ethics.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 476720

LOS ANGELES, CA / ACCESSWIRE / September 29, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Blue Apron Holdings, Inc. (“Blue Apron” or the “Company”) (NYSE: APRN) for possible violations of federal securities laws related to its initial public offering on June 29, 2017 (the “IPO”). Investors, who purchased or otherwise acquired Blue Apron shares pursuant and/or traceable to the IPO, should contact the firm prior to the October 16, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet, and until a class is certified, you are not considered to be represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, the Registration Statement filed in connection with the IPO failed to disclose that: Blue Apron decided to significantly reduce spending on advertising in Q2 2017, hurting sales and profit margins in future quarters; that the Company was experiencing difficulty with customer retention due to orders not arriving on time or with all expected ingredients; and that the Company was experiencing delayed orders in Q2 2017 related to its new factory in Linden, New Jersey. Since the IPO, Blue Apron’s share price has fallen materially, which has caused investors harm according to the lawsuit.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and rules of ethics.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 476721

LOS ANGELES, CA / ACCESSWIRE / September 29, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Rayonier Advanced Materials Inc. (“Rayonier” or the “Company”) (NYSE: RYAM) regarding possible violations of federal securities laws from October 29, 2014 through August 19, 2015, inclusive (the “Class Period”). Investors who purchased or otherwise acquired Rayonier shares during the Class Period should contact the firm prior to the October 16, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet, and until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, throughout the Class Period, Rayonier issued materially false and misleading statements, and/or failed to disclose adverse information, about its business and outlook. Specifically, despite the Company’s claims during the Class Period that in 2015 Rayonier “will be able to maintain or increase [its] share of volume at each of [its] top 10 customers,” since 2013, one of its top three customers, Eastman Chemical Company (“Eastman”), had been informing Rayonier of its competitors’ pricing and had requested that Rayonier respond to declines in market pricing. This led to a protracted dispute between Rayonier and Eastman over the “meet and release” provision of their agreement.

On August 18, 2015, the Company filed a form 8-K with the U.S. Securities and Exchange Commission, informing investors that the Company filed an action against Eastman regarding its “chemical cellulose specialty products contract with Eastman.” On August 19, 2015, Rayonier issued a press release further explaining the dispute with Eastman, stating that the language in the contract at issue involved the “meet or release” provisions of the agreement, which allowed Eastman to obtain “third party offers that meet the requirements of the Supply Agreement for similar cellulose specialties products, and would require [Rayonier] to either meet such price or release the volume, thereby allowing Eastman to purchase the volume from the third party.” The release also revealed that on August 12, 2017, Eastman filed an action against the Company regarding the same “meet or release” provisions in their contract. Upon release of this information, shares of Rayonier fell in value materially, which caused investors harm according to the Complaint.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 476722

LOS ANGELES, CA / ACCESSWIRE / September 29, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against ZTO Express (Cayman) Inc. (“ZTO” or the “Company”) (NYSE: ZTO) for possible violations of federal securities laws in connection with its initial public offering on October 27, 2016 (the “IPO”). Investors who purchased or otherwise acquired ZTO shares pursuant and/or traceable to the IPO, should contact the firm before the October 16, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet, and until a class is certified, you are not considered to be represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, the Registration Statement and Prospectus issued in connection with the IPO contained materially false and misleading information, and/or failed to disclose material information, to investors. At the time of the IPO, ZTO improperly inflated its stated profit margins by keeping certain low-margin segments of its business out of its financial statements. The Company failed to disclose that it used a system of “network partners” to handle lower-margin pickup and delivery services, while maintaining ownership of core hub operations. The Company was able to exaggerate its profit margins to investors by keeping the “network partners” businesses off its own books. Since the IPO, ZTO’s stock price fell materially, which caused investors harm according to the Complaint.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 476725

IRVINE, CA / ACCESSWIRE / September 29, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against The Advisory Board Company (“Advisory Board” or the “Company”) (NASDAQ: ABCO). Investors who purchased or otherwise acquired shares from January 21, 2015 through February 23, 2016, inclusive (the “Class Period”), are encouraged to contact the Firm by October 2, 2017, the lead plaintiff motion deadline.

If you purchased shares of Advisory Board during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet, and until certification occurs, you are not represented by an attorney. You may also choose to take no action and remain a passive class member.

The Complaint alleges that throughout the Class Period, Advisory Board made materially false and/or misleading statements, and/or failed to disclose, that there were severe integration problems associated with its acquisition of Royall and, as a consequence of these integration problems, the Company had no basis to increase the revenue guidance for Royall during the Class Period. When this information reached the public, Advisory Board’s stock price decreased materially, which harmed investors according to the Complaint.

If you want to learn more about this lawsuit, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 476709

IRVINE, CA / ACCESSWIRE / September 29, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE: EVHC). Investors who purchased or otherwise acquired Envision shares from March 2, 2015 through July 21, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the October 3, 2017 lead plaintiff motion deadline.

If you purchased shares of Envision during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet, and until certification occurs, you are not represented by an attorney. You may also choose to take no action and remain a passive class member.

According to the Complaint, throughout the Class Period, Envision made materially false and/or misleading statements, and/or failed to disclose material information, to investors. On July 24, 2017, The New York Times reported that hospitals associated with the Company’s subsidiary, EmCare Holdings, Inc., were disproportionately likely to engage in “surprise billing,” in which patients who sought treatment at in-network facilities were treated by out-of-network physicians and then billed at higher rates. Following this news, Envision’s stock price fell materially, which harmed investors according to the Complaint.

If you wish to learn more about this lawsuit, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 476710

IRVINE, CA / ACCESSWIRE / September 29, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Applied Optoelectronics, Inc. (“Applied Optoelectronics” or the “Company”) (NASDAQ: AAOI). Investors who purchased or otherwise acquired shares from July 13, 2017 through August 3, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before October 4, 2017, the lead plaintiff motion deadline.

If you purchased Applied Optoelectronics shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet, and until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Applied Optoelectronics made false and/or misleading statements and/or failed to disclose: that a major customer was decreasing its purchases of the Company’s 40G receivers; that the loss of this business would have a signfiicant negative impact on the Company’s financial performance; and that as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. When this news went public, Applied Optoelectronics’ share price fell materially, which caused investors harm according to the lawsuit.

If you want to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 476711